Concepedia

Catalina Barceló

CB

Statistics

Publications

9

Citations

237

H-Index

9

Active since

2015

Affiliations

University of Lausanne(Current)

University of Geneva

University of Zurich

University Hospital of Zurich

University of Basel

Catalina Barceló is an author at University of Lausanne specializing in drug resistance, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2015–2023

9

Publications

9

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals

Manel Aouri, Catalina Barceló, Monia Guidi et al. · Antimicrobial Agents and Chemotherapy · 2016 · 51 citations · Full text

, , +16

Population pharmacokinetics of dolutegravir: influence of drug–drug interactions in a real-life setting

Catalina Barceló, Manel Aouri, Perrine Courlet et al. · Journal of Antimicrobial Chemotherapy · 2019 · 36 citations · Full text

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183

Laura E. de Vries, Patrick A.M. Jansen, Catalina Barceló et al. · Nature Communications · 2022 · 32 citations · Full text

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid

Manel Aouri, Catalina Barceló, Béatrice Ternon et al. · Drug Metabolism and Disposition · 2015 · 31 citations · Full text

Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.

Bridget E. Barber, Melissa Fernandez, Hardik B. Patel et al. · LSTM Online Archive (Liverpool School of Tropical Medicine) · 2022 · 30 citations

1–5 of 9